M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
Clinical trial NCT03833661 · COMPLETED
Trial details
- NCT number
- NCT03833661
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2020-11-09
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.